THROMBOCYTOPENIA

This study tested whether the drug romiplostim can help prevent dangerously low platelet counts caused by chemotherapy in people with lymphoma. Eleven adults with lymphoma who were receiving certain chemotherapy regimens took part. The goal was to see if romiplostim could reduce …

This early-stage trial tested a new drug called PN20 in 24 adults with lymphoma or solid tumors who had low platelets from chemotherapy. The goal was to see if a single shot before chemo is safe and could help prevent dangerously low platelet counts. Researchers monitored patient…

This study checked if a new generic version of eltrombopag (a drug that helps increase low blood platelets) works the same as the original brand-name drug. It involved 36 healthy adults in China who took both versions after a meal. The goal was to see if the generic is a safe and…

This study collected one blood sample from 40 adults with very low platelets (30,000/mcl or less) due to blood cancers or their treatment. The goal was to gather samples for research, not to provide treatment. Participants could not have had chemotherapy in the last 24 hours or b…

This study looked at 68 people who need frequent platelet transfusions because of low platelet counts. Researchers tested whether a new method (C1q binding) could better predict if a transfusion would help compared to the standard test. They used stored blood samples to compare t…

This study looked at whether it is safe to lower the platelet count that triggers a transfusion before placing a central venous catheter (a special IV line) in patients with blood disorders. Researchers compared a new, lower threshold (10,000 platelets per cubic millimeter) to th…